FDA to make 510(k) changes by September
January 27, 2010 by MassDevice staff
The Food & Drug Administration's Center for Devices and Radiological Health outlines an aggressive, four-part plan for 2010 and beyond, including substantial changes to the 510(k) and PMA approval processes and a possible re-organization of the entire agency this year.
Meet the new boss, who is definitely not the same as the old boss.
The Center for Devices and Radiological Health and new director Jeffrey Shuren are looking to shake things up at the Food & Drug Administration's medical device oversight arm, according to a new set of strategic priorities for 2010 and the following years. The changes include an overhaul of the 510(k) and PMA approval processes, slated to go into effect by September, and a 2013 release date for a unique device identifier system.
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- When regulators are ignored
- FDA Issues Draft Guidance to Help Companies Distinguish Between a Voluntary Medical Device Recall and a Product Enhancement
- Patient and family engagement in ICUs
- A day in the life: A pediatric neurosurgeon's vision
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
Navigation
NEWS
Medical device tax: Theragenics, layoffs and the essence of the fight for repeal
Theragenics' recent rhetoric about the medical device tax captures many of the repeal movement's high...
FDA green-lights 1st HbA1cDx diabetes test | MassDevice.com On Call
U.S. healthcare regulators clear Roche's COBAS INTEGRA 800 Tina-quant HbA1cDx assay, the 1st HbA1c...
MassDevice.com +3 | The top 3 med-tech stories for May 23, 2013
If you read nothing else today, make sure you're still in the know with MassDevice +3.
EuroPCR: Volcano touts positive early results for its lesion assessment system
Volcano posts positive preliminary findings demonstrating the benefit of a hybrid iFR/FFR approach to...
European regulators green-light valve-in-valve procedures
Medical device giant Medtronic says its European CE Mark is the 1st ever regulatory approval for...
